Search

Your search keyword '"Golka, K."' showing total 523 results
Start Over Author "Golka, K."
523 results on '"Golka, K."'

3. The Real Daily Need for Incontinence Aids and Appliances in Patients with Neurogenic Bladder Dysfunction in a Community Setting in Germany

Author

Böthig R, Domurath B, Kutzenberger J, Bremer J, Kurze I, Kaufmann A, Pretzer J, Klask JP, Kowald B, Tiburtius C, Golka K, Hirschfeld S, and Thietje R

Subjects
neurogenic lower urinary tract dysfunction, urological aids and appliances, bladder management, intermittent catheterization, incontinence, spinal cord injury, spina bifida, Medicine (General), R5-920
Abstract

Ralf Böthig,1 Burkhard Domurath,2 Johannes Kutzenberger,3 Jörn Bremer,4 Ines Kurze,5 Albert Kaufmann,6 Jana Pretzer,7 Jens-Peter Klask,8 Birgitt Kowald,9 Christian Tiburtius,1 Klaus Golka,10 Sven Hirschfeld,11 Roland Thietje11 1Department of Neuro-Urology, Centre for Spinal Cord Injuries, BG Klinikum Hamburg, Hamburg, Germany; 2Centre for Neuro-Urology, Kliniken Beelitz, Neurologische Rehabilitationsklinik, Beelitz-Heilstätten, Germany; 3Department of Neuro-Urology, Kliniken Hartenstein UKR, Bad Wildungen, Germany; 4Centre for Spinal Cord Injuries, BDH-Klinik Greifswald, Greifswald, Germany; 5Centre for Spinal Cord Injuries, Department of Paraplegiology and Neuro-Urology, Zentralklinik Bad Berka, Bad Berka, Germany; 6Department of Neuro-Urology, Kliniken Maria Hilf GmbH, Mönchengladbach, Germany; 7Department of Urology and Neuro-Urology, BG Trauma Hospital Berlin, Berlin, Germany; 8BG Trauma Hospital Duisburg, Duisburg, Germany; 9Biomechanical Laboratory, BG Klinikum Hamburg, Hamburg, Germany; 10Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund(IfADo), Dortmund, Germany; 11Centre for Spinal Cord Injuries, BG Klinikum Hamburg, Hamburg, GermanyCorrespondence: Ralf BöthigDepartment of Neuro-Urology, Centre for Spinal Cord Injuries, BG Klinikum Hamburg, Bergedorfer Str. 10, Hamburg 21033, GermanyTel +49 40 7306 2608Fax +49 40 7306 2621Email r.boethig@bgk-hamburg.dePurpose: For successful long-term rehabilitation of patients with neurogenic lower urinary tract dysfunction (NLUTD), it is necessary to define the objective requirement for urological aids based on a scientifically validated basis.Methods: This was a cross-sectional multicenter study, based on a questionnaire. Data concerning bladder management and daily consumption of urological appliances for patients with NLUTD in a community setting were collected through a standardized survey.Results: Seven hundred and sixty-seven records were analyzed: 543 males, 221 females (N/A = 3). Patients using intermittent catheterization (n= 608) required 5.06 (mean) single-use catheters per day. Out of them, 94 (15.5%) required additional pads (mean: 2.29 per day), 34 patients (5.6%) additionally used pants (mean: 2.55 per day) and 46 patients (7.6%) utilized condom catheters (mean: 3.81 per day) between catheterizations. Among all, 126 patients (16.4%) used pads (mean: 5.03 per day), and 51 patients (6.6%) used pants (mean: 3.03 per day). Women needed both pads (p

Published
2020

6. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights

Author

Koutros, S, Kiemeney, LA, Choudhury, PP, Milne, RL, de Maturana, EL, Ye, Y, Joseph, V, Florez-Vargas, O, Dyrskjot, L, Figueroa, J, Dutta, D, Giles, GG, Hildebrandt, MAT, Offit, K, Kogevinas, M, Weiderpass, E, McCullough, ML, Freedman, ND, Albanes, D, Kooperberg, C, Cortessis, VK, Karagas, MR, Johnson, A, Schwenn, MR, Baris, D, Furberg, H, Bajorin, DF, Cussenot, O, Cancel-Tassin, G, Benhamou, S, Kraft, P, Porru, S, Carta, A, Bishop, T, Southey, MC, Matullo, G, Fletcher, T, Kumar, R, Taylor, JA, Lamy, P, Prip, F, Kalisz, M, Weinstein, SJ, Hengstler, JG, Selinski, S, Harland, M, Teo, M, Kiltie, AE, Tardon, A, Serra, C, Carrato, A, Garcia-Closas, R, Lloreta, J, Schned, A, Lenz, P, Riboli, E, Brennan, P, Tjonneland, A, Otto, T, Ovsiannikov, D, Volkert, F, Vermeulen, SH, Aben, KK, Galesloot, TE, Turman, C, De Vivo, I, Giovannucci, E, Hunter, DJ, Hohensee, C, Hunt, R, V. Patel, A, Huang, W-Y, Thorleifsson, G, Gago-Dominguez, M, Amiano, P, Golka, K, Stern, MC, Yan, W, Liu, J, Alfred, S, Katta, S, Hutchinson, A, Hicks, B, Wheeler, WA, Purdue, MP, McGlynn, KA, Kitahara, CM, Haiman, CA, Greene, MH, Rafnar, T, Chatterjee, N, Chanock, SJ, Wu, X, Real, FX, Silverman, DT, Garcia-Closas, M, Stefansson, K, Prokunina-Olsson, L, Malats, N, Rothman, N, Koutros, S, Kiemeney, LA, Choudhury, PP, Milne, RL, de Maturana, EL, Ye, Y, Joseph, V, Florez-Vargas, O, Dyrskjot, L, Figueroa, J, Dutta, D, Giles, GG, Hildebrandt, MAT, Offit, K, Kogevinas, M, Weiderpass, E, McCullough, ML, Freedman, ND, Albanes, D, Kooperberg, C, Cortessis, VK, Karagas, MR, Johnson, A, Schwenn, MR, Baris, D, Furberg, H, Bajorin, DF, Cussenot, O, Cancel-Tassin, G, Benhamou, S, Kraft, P, Porru, S, Carta, A, Bishop, T, Southey, MC, Matullo, G, Fletcher, T, Kumar, R, Taylor, JA, Lamy, P, Prip, F, Kalisz, M, Weinstein, SJ, Hengstler, JG, Selinski, S, Harland, M, Teo, M, Kiltie, AE, Tardon, A, Serra, C, Carrato, A, Garcia-Closas, R, Lloreta, J, Schned, A, Lenz, P, Riboli, E, Brennan, P, Tjonneland, A, Otto, T, Ovsiannikov, D, Volkert, F, Vermeulen, SH, Aben, KK, Galesloot, TE, Turman, C, De Vivo, I, Giovannucci, E, Hunter, DJ, Hohensee, C, Hunt, R, V. Patel, A, Huang, W-Y, Thorleifsson, G, Gago-Dominguez, M, Amiano, P, Golka, K, Stern, MC, Yan, W, Liu, J, Alfred, S, Katta, S, Hutchinson, A, Hicks, B, Wheeler, WA, Purdue, MP, McGlynn, KA, Kitahara, CM, Haiman, CA, Greene, MH, Rafnar, T, Chatterjee, N, Chanock, SJ, Wu, X, Real, FX, Silverman, DT, Garcia-Closas, M, Stefansson, K, Prokunina-Olsson, L, Malats, N, and Rothman, N

Abstract

BACKGROUND: Genomic regions identified by genome-wide association studies (GWAS) for bladder cancer risk provide new insights into etiology. OBJECTIVE: To identify new susceptibility variants for bladder cancer in a meta-analysis of new and existing genome-wide genotype data. DESIGN, SETTING, AND PARTICIPANTS: Data from 32 studies that includes 13,790 bladder cancer cases and 343,502 controls of European ancestry were used for meta-analysis. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSES: Log-additive associations of genetic variants were assessed using logistic regression models. A fixed-effects model was used for meta-analysis of the results. Stratified analyses were conducted to evaluate effect modification by sex and smoking status. A polygenic risk score (PRS) was generated on the basis of known and novel susceptibility variants and tested for interaction with smoking. RESULTS AND LIMITATIONS: Multiple novel bladder cancer susceptibility loci (6p.22.3, 7q36.3, 8q21.13, 9p21.3, 10q22.1, 19q13.33) as well as improved signals in three known regions (4p16.3, 5p15.33, 11p15.5) were identified, bringing the number of independent markers at genome-wide significance (p < 5 × 10-8) to 24. The 4p16.3 (FGFR3/TACC3) locus was associated with a stronger risk for women than for men (p-interaction = 0.002). Bladder cancer risk was increased by interactions between smoking status and genetic variants at 8p22 (NAT2; multiplicative p value for interaction [pM-I] = 0.004), 8q21.13 (PAG1; pM-I = 0.01), and 9p21.3 (LOC107987026/MTAP/CDKN2A; pM-I = 0.02). The PRS based on the 24 independent GWAS markers (odds ratio per standard deviation increase 1.49, 95% confidence interval 1.44-1.53), which also showed comparable results in two prospective cohorts (UK Biobank, PLCO trial), revealed an approximately fourfold difference in the lifetime risk of bladder cancer according to the PRS (e.g., 1st vs 10th decile) for both smokers and nonsmokers. CONCLUSIONS: We report novel loci associated

Published
2023

7. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.

Author

Koutros, S., Kiemeney, L.A., Pal Choudhury, P., Milne, R.L., Lopez de Maturana, E., Ye, Y., Joseph, V., Florez-Vargas, O., Dyrskjøt, L., Figueroa, J., Dutta, D., Giles, G.G., Hildebrandt, M.A.T., Offit, K., Kogevinas, M., Weiderpass, E., McCullough, M.L., Freedman, N.D., Albanes, D., Kooperberg, C., Cortessis, V.K., Karagas, M.R., Johnson, A., Schwenn, M.R., Baris, D., Furberg, H., Bajorin, D.F., Cussenot, O., Cancel-Tassin, G., Benhamou, S., Kraft, P., Porru, S., Carta, A., Bishop, T., Southey, M.C., Matullo, G., Fletcher, T., Kumar, R., Taylor, J.A., Lamy, P., Prip, F., Kalisz, M., Weinstein, S.J., Hengstler, J.G., Selinski, S., Harland, M., Teo, M., Kiltie, A.E., Tardón, A., Serra, C., Carrato, A., García-Closas, R., Lloreta, J., Schned, A., Lenz, P., Riboli, E., Brennan, P., Tjønneland, A., Otto, T., Ovsiannikov, D., Volkert, F., Vermeulen, S.H., Aben, K.K.H., Galesloot, T.E., Turman, C., Vivo, I. De, Giovannucci, E., Hunter, D.J., Hohensee, C., Hunt, R., Patel, A.V., Huang, W.Y., Thorleifsson, G., Gago-Dominguez, M., Amiano, P., Golka, K., Stern, M.C., Yan, W., Liu, J., Li, S.A., Katta, S., Hutchinson, A., Hicks, B., Wheeler, W.A., Purdue, M.P., McGlynn, K.A., Kitahara, C.M., Haiman, C.A., Greene, M.H., Rafnar, T., Chatterjee, N., Chanock, S.J., Wu, X., Real, F.X., Silverman, D.T., Garcia-Closas, M., Stefansson, K., Prokunina-Olsson, L., Malats, N., Rothman, N., Koutros, S., Kiemeney, L.A., Pal Choudhury, P., Milne, R.L., Lopez de Maturana, E., Ye, Y., Joseph, V., Florez-Vargas, O., Dyrskjøt, L., Figueroa, J., Dutta, D., Giles, G.G., Hildebrandt, M.A.T., Offit, K., Kogevinas, M., Weiderpass, E., McCullough, M.L., Freedman, N.D., Albanes, D., Kooperberg, C., Cortessis, V.K., Karagas, M.R., Johnson, A., Schwenn, M.R., Baris, D., Furberg, H., Bajorin, D.F., Cussenot, O., Cancel-Tassin, G., Benhamou, S., Kraft, P., Porru, S., Carta, A., Bishop, T., Southey, M.C., Matullo, G., Fletcher, T., Kumar, R., Taylor, J.A., Lamy, P., Prip, F., Kalisz, M., Weinstein, S.J., Hengstler, J.G., Selinski, S., Harland, M., Teo, M., Kiltie, A.E., Tardón, A., Serra, C., Carrato, A., García-Closas, R., Lloreta, J., Schned, A., Lenz, P., Riboli, E., Brennan, P., Tjønneland, A., Otto, T., Ovsiannikov, D., Volkert, F., Vermeulen, S.H., Aben, K.K.H., Galesloot, T.E., Turman, C., Vivo, I. De, Giovannucci, E., Hunter, D.J., Hohensee, C., Hunt, R., Patel, A.V., Huang, W.Y., Thorleifsson, G., Gago-Dominguez, M., Amiano, P., Golka, K., Stern, M.C., Yan, W., Liu, J., Li, S.A., Katta, S., Hutchinson, A., Hicks, B., Wheeler, W.A., Purdue, M.P., McGlynn, K.A., Kitahara, C.M., Haiman, C.A., Greene, M.H., Rafnar, T., Chatterjee, N., Chanock, S.J., Wu, X., Real, F.X., Silverman, D.T., Garcia-Closas, M., Stefansson, K., Prokunina-Olsson, L., Malats, N., and Rothman, N.

Abstract

01 juli 2023, Item does not contain fulltext, BACKGROUND: Genomic regions identified by genome-wide association studies (GWAS) for bladder cancer risk provide new insights into etiology. OBJECTIVE: To identify new susceptibility variants for bladder cancer in a meta-analysis of new and existing genome-wide genotype data. DESIGN, SETTING, AND PARTICIPANTS: Data from 32 studies that includes 13,790 bladder cancer cases and 343,502 controls of European ancestry were used for meta-analysis. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSES: Log-additive associations of genetic variants were assessed using logistic regression models. A fixed-effects model was used for meta-analysis of the results. Stratified analyses were conducted to evaluate effect modification by sex and smoking status. A polygenic risk score (PRS) was generated on the basis of known and novel susceptibility variants and tested for interaction with smoking. RESULTS AND LIMITATIONS: Multiple novel bladder cancer susceptibility loci (6p.22.3, 7q36.3, 8q21.13, 9p21.3, 10q22.1, 19q13.33) as well as improved signals in three known regions (4p16.3, 5p15.33, 11p15.5) were identified, bringing the number of independent markers at genome-wide significance (p < 5 × 10(-8)) to 24. The 4p16.3 (FGFR3/TACC3) locus was associated with a stronger risk for women than for men (p-interaction = 0.002). Bladder cancer risk was increased by interactions between smoking status and genetic variants at 8p22 (NAT2; multiplicative p value for interaction [p(M-I)] = 0.004), 8q21.13 (PAG1; p(M-I) = 0.01), and 9p21.3 (LOC107987026/MTAP/CDKN2A; p(M-I) = 0.02). The PRS based on the 24 independent GWAS markers (odds ratio per standard deviation increase 1.49, 95% confidence interval 1.44-1.53), which also showed comparable results in two prospective cohorts (UK Biobank, PLCO trial), revealed an approximately fourfold difference in the lifetime risk of bladder cancer according to the PRS (e.g., 1st vs 10th decile) for both smokers and nonsmokers. CONCLUSIONS: We report novel loci ass

Published
2023

8. Beruflich bedingte urologische Tumoren

Author

Jungmann, O., Schöps, W., Golka, K., and Rohde, D.

Abstract

Der Berufsanamnese kommt bei urologischen Krebserkrankungen, in erster Linie urothelialen Erkrankungen, eine hohe Bedeutung zu. Bis zu 7 % (Männer) bzw. 2 % (Frauen) der Harnblasenkrebserkrankungen könnten beruflich bedingt sein. Die Anzahl der gemeldeten und anerkannten Fälle ist aber trotz steigender Tendenz noch immer deutlich zu gering. Hauptkarzinogene sind krebserzeugende aromatische Amine, die in der chemischen Industrie lange verbreitet waren, aber auch in anderen, auf den ersten Blick nicht typischen Berufen angetroffen werden. Eine strukturierte Berufsanamnese kann mit geringem Aufwand zu einem Verdacht führen, der dann zur Meldung an den Träger der gesetzlichen Unfallversicherung führen muss. Diese Meldung ist wenig aufwendig und wird vergütet. Im sich daran anschließenden Berufskrankheitenanerkennungsverfahren wird ermittelt, ob eine Exposition gegenüber einem Stoff bestand, der geeignet ist, eine Krebserkrankung auszulösen. Ist dies der Fall, wird in einer arbeitsmedizinischen Zusammenhangsbegutachtung die Wahrscheinlichkeit geklärt, ob eine Berufserkrankung vorliegt. Im Anerkennungsfall klärt ein urologischer Gutachter die Höhe der in den meisten Fällen rentenberechtigenden Minderung der Erwerbsfähigkeit (MdE). Die Anerkennung einer Berufskrankheit (BK) bringt den Patienten sehr große Vorteile. So wird in der Regel eine Rentegewährt, und die Behandlungskosten werden unbudgetiert nach der UV-GOÄ (Gebührenordnung für Ärzte, Gesetzliche Unfallversicherung) übernommen. In patients with urological cancer, especially urothelial cancer, a detailed history of occupational risks should be taken. Up to 7 (men) and 2% (women) of bladder cancers could be due to occupational exposure to carcinogens. In Germany, the number of reported cases of suspected and recognized occupational diseases is increasing, albeit still clearly too low. The primary carcinogens are carcinogenic aromatic amines, widely used in the chemical industry of the last century but also found in other less obvious occupations. A structured standardized occupational history, taken in all patients with urological cancer from apprenticeship on, may lead to a larger number of reported suspicions. Reporting a suspicious case to the statutory accident insurance provider—an act which consumes minimal resources and is reimbursed—leads to investigations in the company where the suspected exposure has taken place to clarify whether there was exposure to carcinogenic substances. If this proves to be the case, a causal evaluation by specialists in occupational health and urology assesses the likelihood that the disease is occupational. Upon recognition of an occupational disease, a urological appraisal evaluates the size of the pensionable reduction in earning capacity which exists in most patients. Recognition of an occupational disease has major advantages for the patient. A pension is ensured in most cases and the statutory accident insurance covers the nonbudgeted treatment costs according to UV-GOÄ (Gebührenordnung für Ärzte, Gesetzliche Unfallversicherung).

Published
2024
Full Text
View/download PDF

9. Das Berufskrankheitenverfahren bei urologischen Erkrankungen

Author

Schöps, W., Zumbé, J., Zellner, M., Jungmann, O., Hengstler, J.G., and Golka, K.

Abstract

Zusammenfassung: Harnblasenkrebs und Nierenzellkarzinom müssen gemäß § 202 SGB VII bei entsprechender beruflicher Exposition als Verdacht auf das Vorliegen einer Berufskrankheit der gesetzlichen Unfallversicherung gemeldet werden. In der Arbeit wird, unter besonderer Betonung des Meldeverfahrens und des Identifizierens möglicher Risikofaktoren mittels eines von den Autoren hierfür entwickelten CD-gestützten Tools, der Ablauf des Berufskrankheitenverfahrens beschrieben.

Published
2024
Full Text
View/download PDF

17. Ethylene Oxide Distribution in Human Blood

Author

Gansewendt, B., Foest, U., Marczynski, B., Golka, K., Hallier, E., Peter, H., Chambers, Philip L., editor, Chambers, Claire M., editor, Wiezorek, Wolf Diether, editor, and Golbs, Siegfried, editor

Published
1991
Full Text
View/download PDF

21. Hämochromatose – eine wichtige, selten frühzeitig gestellte Differentialdiagnose in der Allgemeinmedizin

Author

Golka, K, Collette, D, Müller, JI, Claus, M, Niedner, H, Römer, HC, and Butzeck, B

Subjects
ddc: 610, Medicine and health
Abstract

Hintergrund: Hämochromatose ist eine genetisch bedingte autosomal-rezessive Eisenstoffwechselstörung, der ein Gendefekt im HFE-Gen zugrunde liegt. Die Homozygotenfrequenz liegt in Mitteleuropa bei 1:400. Die Penetranz wird bei Frauen auf 1% (Beginn häufig erst nach der Menopause!) [zum vollständigen Text gelangen Sie über die oben angegebene URL]

Published
2021
Full Text
View/download PDF

36. Traumatic spinal cord injury confers bladder cancer risk to patients managed without chronic indwelling urinary catheters: Lessons from a comparison of clinical data with the national database

Author

Böthig, R., primary, Reckwitz, T., additional, Tiburtius, C., additional, Fiebag, K., additional, Kowald, B., additional, Hirschfeld, S., additional, Thietje, R., additional, Kurze, I., additional, Schöps, W., additional, Böhme, H., additional, Kaufmann, A., additional, Zellner, M., additional, Kadhum, T., additional, and Golka, K., additional

Published
2020
Full Text
View/download PDF

38. Posters

Author

Föllmann, W., primary, Dörrenhaus, A., additional, Flieger, A., additional, Golka, K., additional, Degen, Gisela H., additional, Groß-Steinmeyer, Kerstin, additional, Weymann, J., additional, Koebe, H. G., additional, Metzler, M., additional, Humpf, Hans-Ulrich, additional, Schmelz, E.-M., additional, Meredith, F. I., additional, Merrill, A. H., additional, Fein, Martin, additional, Fuchs, Karl-Hermann, additional, Diem, Stefanie, additional, Herderich, Markus, additional, Richling, Elke, additional, Häring, Dietmar, additional, Schreier, Peter, additional, Vollenbröker, Marc, additional, Eichner, Karl, additional, Hofer, Monika, additional, Janzowski, Christine, additional, Loeppky, Richard N., additional, Eisenbrand, Gerhard, additional, Wörner, Wolfgang, additional, Müller, Martina, additional, Schmitz, Hans-Joachim, additional, Schrenk, Dieter, additional, Baum, Matthias, additional, Köhl, Werner, additional, Hecht, Steven S., additional, Amin, Shantu, additional, Guengerich, F. Peter, additional, Burkart, Martin, additional, Vetter, Aribert, additional, Ritter, Eva, additional, Meilike, Christiane, additional, Scherthan, Harry, additional, Zankl, Heinrich, additional, Genzlinger, A., additional, Zimmermann, I., additional, Glaab, V., additional, Samimi, E., additional, Pool-Zobel, B. L., additional, Landsiedel, Robert, additional, Andrae, U., additional, Kuhlow, A., additional, Scholtyssek, M., additional, Glatt, H. R., additional, Hartwig, Andrea, additional, Gröblinghoff, U. D., additional, Hiemstra, Y., additional, Mullenders, L. H. F., additional, Guth, S., additional, Seng, D., additional, Böhm, S., additional, Mußler, B., additional, Jacobs, Eric, additional, Kulling, S. E., additional, Lehmann, Leane, additional, Mayer, S., additional, Glei, Michael, additional, Spänkuch, B., additional, Rechkemmer, Gerhard, additional, Stahl, Wilhelm, additional, Nicolai, S., additional, Clairmont, A., additional, Sies, H., additional, Schneider, Matthias, additional, Diemer, Kerstin, additional, Engelhart, Karin, additional, Trommer, Wolfgang E., additional, Biesalski, Hans K., additional, Kopp-Schneider, Annette, additional, Lutz, Werner K., additional, Müller, Stefan O., additional, Schmitt, Marko, additional, Dekant, Wolfgang, additional, Stopper, Helga, additional, Schlatter, Josef, additional, Simmering, R., additional, Schneider, Heiko, additional, Blaut, M., additional, Pforte, Holger, additional, Hempel, Jürg, additional, Jacobasch, Gisela, additional, Niederberger, Ellen, additional, Meiers, Susanne, additional, Tang, W. C., additional, Marko, D., additional, Wenzel, Uwe, additional, Kuntz, Sabine, additional, Storcksdieck, Stefan, additional, Jambor, Ulrike, additional, and Daniel, Hannelore, additional

Published
2006
Full Text
View/download PDF

39. Das Mesotheliom der Tunica vaginalis des Hodens – ein Fall für die Meldung eines Verdachtes auf eine Berufskrankheit

Author

Ebbinghaus-Mier, D, Ebbinghaus, R, Prager, HM, Schöps, W, and Golka, K

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Mesotheliome sind äußerst aggressive, nahezu ausschließlich durch Asbest ausgelöste Tumoren. Sie können überall da auftreten, wo Mesothel vorhanden ist – also neben Pleura, Peritoneum und Pericard auch Tunica vaginalis des Hodens, die eine Ausstülpung[zum vollständigen Text gelangen Sie über die oben angegebene URL], 66. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie

Published
2020
Full Text
View/download PDF

40. Blasenkarzinom als Spätfolge einer Querschnittlähmung. Vergleich klinischer Daten mit dem RKI-Zentrum für Krebsregisterdaten

Author

Böthig, R, Tiburtius, C, Fiebag, K, Hirschfeld, S, Thietje, R, Kurze, I, Kaufmann, A, Schöps, W, Kadhum, T, and Golka, K

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Fragestellung: Unterscheidet sich das Harnblasenkarzinom (HB-Ca.) bei querschnittgelähmten Patienten (spinal cord injury/disease; SCI/D) vom dem der Normalbevölkerung? Methode: Vergleich der Daten einer retrospektiven Single-Center-Auswertung von konsekutiven Patientendaten[zum vollständigen Text gelangen Sie über die oben angegebene URL], 66. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results